The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Simonov A.N.

Mental Health Research Center, Moscow, Russia

Klyushnik T.P.

Scientific center of mental health, Moscow, Russia

Androsova L.V.

Scientific center of mental health, Moscow, Russia

Mikhaĭlova N.M.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN

Quantification of the relationship between inflammatory markers and Alzheimer’s disease

Authors:

Simonov A.N., Klyushnik T.P., Androsova L.V., Mikhaĭlova N.M.

More about the authors

Read: 962 times


To cite this article:

Simonov AN, Klyushnik TP, Androsova LV, Mikhaĭlova NM. Quantification of the relationship between inflammatory markers and Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5):58‑63. (In Russ.)
https://doi.org/10.17116/jnevro20181185158

Recommended articles:
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19

References:

  1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging — Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270-279. https://doi.org/10.1016/j.jalz.2011.03.008
  2. Licastro F, Pedrini S, Caputo L, Annoni G, Davis LJ, Ferri C, Casadei V, Grimaldi LM. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain? J Neuroimmunol. 2000;103(1):97-102.
  3. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frölich M, Hofman A, Jolles J, Breteler MM, Westendorp RG. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55(5):708-716. https://doi.org/10.1111/j.1532-5415.2007.01159.x
  4. Holmes C, Cunningham C, Zotova E, Culliford D, and Perry VH. Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology. 2011;77(3):212-218. https://doi.org/10.1212/WNL.0b013e318225ae07
  5. Varma VR, Varma S, An Y, Hohman TJ, Seddighi S, Casanova R, Beri A, Dammer EB, Seyfried NT, Pletnikova O, Moghekar A, Wilson MR, Lah JJ, O’Brien RJ, Levey AI, Troncoso JC, Albert MS, Thambisetty M. Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injurythrough the RCAN1 pathway. Mol Psychiatry. 2017;22(1):13-23. https://doi.org/10.1038/mp.2016.206
  6. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frölich M, Hofman A, Jolles J, Breteler MM, Westendorp RG. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55(5):708-716. https://doi.org/10.1111/j.1532-5415.2007.01159.x
  7. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilä IM, Helkala EL, Gylling H, Nissinen A, Rauramaa R. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing. 2007;36(4): 443-448.
  8. Androsova LV, Mikhailova NM, Zozulya SA, Dupin AM, Rassadina GA, Lavrent’eva NV, Klyushnik TP. Markery vospaleniya pri bolezni Al’tsgeimera i sosudistoi dementsii. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113:2: 49-53. (In Russ)
  9. Klyushnik T.P., Androsova LV, Mikhailova NM, Sokolov AV, Kostevich VA, Zakharova ET, Vasil’ev VB. Potentsial’nye markery bolezni Al’tsgeimera, assotsiirovannye s vospaleniem. Psikhiatriya (Nauchno-prakticheskii zhurnal). 2014;61(01): 26-32. (In Russ)
  10. Androsova L, Mikhaylova N, Zozulya S, Dupin A, Klyushnik T. A comparative study of innate immunity markers in Alzheimer’s disease, Mixed dementia and Vascular dementia. International Journal of Clinical Neurosciences and Mental Health. 2016;3(suppl 1):03. https://doi.org/10.21035/ijcnmh.2016.3(Suppl.1).S03
  11. Ashby D, West CR, Ames D. The ordered logistic regression model in psychiatry: rising prevalence of dementia in old people’s homes. Stat Med. 1989;8(11):1317-1326. https://doi.org/10.1002/sim.4780081104
  12. Fleiss JL, Williams JB, Dubro AF. The logistic regression analysis of psychiatric data. J Psychiatr Res. 1986;20(3):195-209. https://doi.org/10.1016/0022-3956(86)90003-8
  13. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley-Interscience; 1989. https://doi.org/10.1002/0471722146

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.